BERGEN BRUNSWIG CORP
S-8, 1999-05-06
DRUGS, PROPRIETARIES & DRUGGISTS' SUNDRIES
Previous: AVNET INC, 8-K, 1999-05-06
Next: BERGEN BRUNSWIG CORP, S-8, 1999-05-06




       As filed with the Securities and Exchange Commission on May , 1999
                                                           Registration No. 333-
================================================================================
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                    FORM S-8
                             REGISTRATION STATEMENT
                                      Under
                           THE SECURITIES ACT OF 1933

                           BERGEN BRUNSWIG CORPORATION
             (Exact name of registrant as specified in its charter)

    New Jersey                                                   22-1444512
(State or other jurisdiction                                 (I.R.S. employer
 of incorporation or organization)                        identification number)

             4000 Metropolitan Drive, Orange, California 92868-3598
               (Address of principal executive offices; zip code)

                            ______________________

        Bergen Brunswig Corporation 1999 Management Stock Incentive Plan
       Bergen Brunswig Corporation 1999 Non-Employee Directors' Stock Plan
                            (Full title of the plans)

                                 Milan A. Sawdei
           Executive Vice President, Chief Legal Officer and Secretary
                           Bergen Brunswig Corporation
                4000 Metropolitan Drive, Orange, California 92868-3598
                                 (714) 385-4000
                      (Name, address and telephone number,
                   including area code, of agent for service)

                                    Copy to:
                               Peter H. Ehrenberg, Esq.
                             Lowenstein Sandler PC
                              65 Livingston Avenue
                    Roseland, New Jersey 07068  (973) 597-2500

                             ______________________

<TABLE>
<CAPTION>

                         Calculation of Registration Fee
=====================================================================================================================
                                                           Proposed              Proposed
Title of Securities             Amount to be          Maximum Offering         Maximum Aggregate        Amount of
to be Registered                 Registered          Price per Share(2)     Offering Price(2)        Registration Fee
- ---------------------------------------------------------------------------------------------------------------------
<S>       <C>               <C>               <C>         <C>                   <C>                      <C>       
Class  A  Common   Stock,
par value $1.50 per share   10,750,000 shares (1)         $19.34                $207,905,000             $57,797.59
=====================================================================================================================
</TABLE>

(1)  Plus  such  additional  shares of Class A Common  Stock as may be  issuable
     pursuant to the anti-dilution provisions of the Bergen Brunswig Corporation
     1999 Management  Stock  Incentive Plan and the Bergen Brunswig  Corporation
     1999 Non-Employee Directors' Stock Plan

(2)  Estimated  solely  for the  purpose of  calculating  the  registration  fee
     pursuant to Rule 457(c) and (h) of the  Securities Act of 1933 on the basis
     of the  average  of the  high and low  sale  prices  for a share of Class A
     Common Stock on the New York Stock Exchange on April 30, 1999.

================================================================================
<PAGE>


           PART II INFORMATION REQUIRED IN THE REGISTRATION STATEMENT

Item 3.  Incorporation of Certain Documents by Reference

          The  Commission  allows us to  "incorporate"  into  this  Registration
Statement information we file with it in other documents. This means that we can
disclose  important  information  to you by  referring to other  documents  that
contain  that  information.   The  information   incorporated  by  reference  is
considered to be part of this  Registration  Statement,  and information we file
later  with  the  Commission  will  automatically   update  and  supersede  this
information.  We incorporate by reference the documents listed below,  except to
the extent  information  in those  documents is different  from the  information
contained in this  Registration  Statement,  and all future documents filed with
the Commission under Sections 13(a),  13(c) or 15(d) of the Securities  Exchange
Act of 1934 until we terminate the offering of these shares.

         (a) the  Company's  Annual  Report  on Form  10-K  for the  year  ended
September 30, 1998, as amended;

         (b) the Company's  Quarterly  Report on Form 10-Q for the quarter ended
December 31, 1998;

         (c) the Company's  Current Reports on Form 8-K dated November 12, 1998,
January 13, 1999, January 26, 1999, April 19, 1999 and April 30, 1999;

         (d) the description of the Common Stock of the Company contained in the
Company's  Registration  Statement on Form S-4 declared  effective by the SEC on
March 16, 1999; and

         (e) the description of the Company's Shareowners' Rights Plan contained
in the Company's Registration Statement on Form 8-A dated February 14, 1994.

          All documents  subsequently  filed by the Company pursuant to Sections
13(a),  13(c), 14 and 15(d) of the Securities Exchange Act of 1934, prior to the
filing of a post-effective amendment which indicates that all securities offered
have been sold or which deregisters all securities then remaining unsold,  shall
be deemed to be incorporated by reference in this registration  statement and to
be a part  hereof  from the date of  filing  of such  documents.  Any  statement
contained  herein or in a document  incorporated or deemed to be incorporated by
reference  herein shall be deemed to be modified or  superseded  for purposes of
this  registration  statement  to the extent that such  statement is modified or
superseded by a  subsequently  filed  document  which also is or is deemed to be
incorporated by reference  herein.  Any such statement so modified or superseded
shall not be deemed to constitute a part of this  registration  statement except
as so modified or superseded.

Item 4.  Description of Securities

         Not applicable.

Item 5.  Interests of Named Experts and Counsel

         Not Applicable.

Item 6.  Indemnification of Directors and Officers

         Under the Company's Restated Certificate of Incorporation, every person
who is or was a  director,  officer,  employee  or agent of the  Company and the
legal  representative  of such a person is entitled  to receive  indemnification
from the Company to the fullest  extent  permitted by law. Under New Jersey law,
directors and officers may be indemnified in certain situations,  subject to the
Company's having taken certain actions and the directors and officers having met
certain specified standards of conduct. In addition, in April, 1986, the Company

<PAGE>

entered into agreements,  which were amended on July 3, 1986 (collectively,  the
"Indemnity  Agreement"),  to indemnify each of its directors against liabilities
and defense  costs to the extent  that such  directors  would have been  insured
under the director and officer liability insurance policies which were in effect
on December 31, 1984 (the "1984 Policy").  The 1984 Policy afforded the broadest
coverage for  liabilities  arising under ERISA and the securities and anti-trust
laws.  The obligation of the Company to indemnify a director under the Indemnity
Agreement is limited to $30 million,  the maximum  coverage  available under the
1984 Policy.  However, the Indemnity Agreement does not limit a director's right
to  recover  in  excess of $30  million  from the  Company  if the  director  is
otherwise  entitled to statutory  indemnification.  The Indemnity  Agreement was
ratified by the shareowners at the annual meeting held on December 17, 1986. The
Company  currently  maintains a directors' and officers'  insurance policy which
provides liability coverage with respect to its directors and officers.

         In  addition,  the  Company's  Restated  Certificate  of  Incorporation
eliminates  the personal  liability of directors and officers to the Company and
its shareowners for monetary damages for acts or omissions  (including negligent
and grossly  negligent  acts or  omissions)  in  violation  of a  director's  or
officer's fiduciary duty of care. The duty of care refers to a fiduciary duty of
directors and officers to manage the affairs of the Company with the same degree
of care as would be applied  by an  "ordinarily  prudent  person  under  similar
circumstances".   The  provisions  of  the  Company's  Restated  Certificate  of
Incorporation  which eliminate the personal  liability of directors and officers
do not, in any way,  eliminate  or limit the  liability of a director or officer
for  breaching  his duty of  loyalty  (i.e.,  the duty to  refrain  from  fraud,
self-dealing and transactions  involving  improper conflicts of interest) to the
Company or its shareowners,  failing to act in good faith, knowingly violating a
law or obtaining an improper  personal benefit and do not have any effect on the
availability of equitable remedies.

         See also the undertakings set forth in response to item 9 herein.

Item 7.  Exemption From Registration Claimed

         Not applicable.

Item 8.  Exhibits

         The Exhibits accompanying this Registration Statement are listed on the
accompanying Exhibit Index.

Item 9.  Undertakings

         (a)      The undersigned registrant hereby undertakes:

         (1) To file, during any period in which offers or sales are being made,
a post-effective amendment to this registration statement:

<PAGE>

               (i) To include any prospectus required by Section 10(a)(3) of the
                   Securities Act of 1933;

              (ii) To  reflect  in  the  prospectus  any  acts or events arising
                   after the effective date  of  the registration  statement (or
                   the    most  recent  post-effective amendment thereof) which,
                   individually  or  in  the  aggregate, represent a fundamental
                   change  in  the  information  set  forth in  the registration
                   statement.  Notwithstanding  the  foregoing,  any increase or
                   decrease in volume of securities offered (if the total dollar
                   value of  securities  offered would not exceed that which was
                   registered) and any deviation from the low  or  high  end  of
                   the estimated  maximum offering range may be reflected in the
                   form of prospectus filed with the Commission pursuant to Rule
                   424(b) if, in the  aggregate, the changes in volume and price
                   represent  no more than a 20% change in the maximum aggregate
                   offering price set forth in the  "Calculation of Registration
                   Fee"  table in the effective registration statement;

              (iii)To include any  material information with respect to the plan
                   of distribution  not previously disclosed in the registration
                   statement or any  material change to such  information in the
                   registration  statement;  provided,  however, that paragraphs
                   (a)(1)(i)  and  (a)(1)(ii)  do not apply if the  registration
                   statement   is on Form  S-3,  Form S-8 or Form  F-3,  and the
                   information  required  to  be  included  in a  post-effective
                   amendment  by those  paragraphs  is  contained   in  periodic
                   reports  filed with or  furnished to the  Commission  by  the
                   registrant  pursuant  to Section 13 or Section  15(d) of  the
                   Securities  Exchange  Act of 1934 that  are  incorporated  by
                   reference in the registration statement.

          (2) That,  for the  purpose of  determining  any  liability  under the
Securities Act of 1933, each such post-effective amendment shall be deemed to be
a new registration statement relating to the securities offered therein, and the
offering of such  securities at that time shall be deemed to be the initial bona
fide offering thereof.

          (3) To remove from registration by means of a post-effective amendment
any of the securities being registered which remain unsold at the termination of
the offering.

          (b) The undersigned registrant hereby undertakes that, for purposes of
determining  any liability  under the Securities Act of 1933, each filing of the
registrant's  annual  report  pursuant to Section  13(a) or Section 15(d) of the
Securities  Exchange  Act of 1934  (and,  where  applicable,  each  filing of an
employee  benefit  plan's  annual  report  pursuant  to  Section  15(d)  of  the
Securities  Exchange  Act of 1934)  that is  incorporated  by  reference  in the
registration  statement  shall  be  deemed  to be a new  registration  statement
relating to the securities offered therein,  and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof.

          (c)  Insofar as  indemnification  for  liabilities  arising  under the
Securities Act of 1933 may be permitted to directors,  officers and  controlling
persons of the registrant  pursuant to the foregoing  provisions,  or otherwise,
the  registrant  has been  advised  that in the opinion of the  Commission  such
indemnification  is against public policy as expressed in the Securities Act and
is,  therefore,  unenforceable.  In the event  that a claim for  indemnification

<PAGE>

against such  liabilities  (other than the payment by the registrant of expenses
incurred or paid by a director,  officer or controlling person of the registrant
in the successful defense of any action, suit or proceeding) is asserted by such
director,  officer or controlling person in connection with the securities being
registered, the registrant will, unless in the opinion of its counsel the matter
has been  settled by  controlling  precedent,  submit to a court of  appropriate
jurisdiction the question whether such  indemnification  by it is against public
policy as  expressed  in the  Securities  Act and will be  governed by the final
adjudication of such issue.



<PAGE>


                                   SIGNATURES

          Pursuant  to the  requirements  of the  Securities  Act of  1933,  the
registrant certifies that it has reasonable grounds to believe that it meets all
of the requirements for filing on Form S-8 and has duly caused this Registration
Statement  to be  signed  on its  behalf  by  the  undersigned,  thereunto  duly
authorized,  in the  City of  Orange,  State of  California,  on the 3rd day of
May, 1999.

                                                BERGEN BRUNSWIG CORPORATION



                                                By: /s/ Milan A. Sawdei
                                                    ____________________________
                                                    Milan A. Sawdei,
                                                    Executive Vice President


          Pursuant  to the  requirements  of the  Securities  Act of 1933,  this
Registration  Statement  has been signed below by the  following  persons in the
capacities indicated on the 3rd day of May, 1999.

/s/ Robert E. Martini*                  Chairman of the
____________________________            Board and Director
Robert E. Martini           

/s/ Donald R. Roden*                    President, Chief
____________________________            Executive Officer and Director
Donald R. Roden        

/s/ Neil F. Dimick*                     Executive Vice President,
____________________________            Chief Financial Officer
Neil F. Dimick                          and Director (Principal
                                        Financial Officer and
                                        Principal Accounting Officer)

/s/ Jose E. Blanco, Sr.*                Director
____________________________
Jose E. Blanco, Sr.

/s/ Rodney H. Brady*                    Director
____________________________
Rodney H. Brady

/s/ Charles C. Edwards*                 Director
____________________________
Charles C. Edwards, M.D.

<PAGE>



/s/ Charles J. Lee*                     Director
____________________________
Charles J. Lee

/s/ George R. Liddle*                   Director
____________________________
George R. Liddle

/s/ James R. Mellor*                    Director
____________________________
James R. Mellor

/s/ George E. Reinhardt, Jr.*           Director
____________________________
George E. Reinhardt, Jr.

/s/ Francis G. Rodgers*                 Director
____________________________
Francis G. Rodgers

*By: /s/ Milan A. Sawdei
_____________________________
      Milan A. Sawdei,
      Attorney-in-Fact



<PAGE>


                                  EXHIBIT INDEX

     4.1  Restated Certificate of Incorporation of Bergen Brunswig  Corporation,
          dated November 13, 1998, is  incorporated  by reference to Exhibit 4.1
          to the  Company's  Post-Effective  Amendment  No. 2 to Form S-3  dated
          December 17, 1998 (file no. 333-63441).

     4.2  By-laws of Bergen Brunswig Corporation, as amended and restated, dated
          November 13, 1998 are  incorporated by reference to Exhibit 4.2 to the
          Company's  Post-Effective  Amendment No. 2 to Form S-3 dated  December
          17, 1998 (file no. 333-63441).

     4.3  Rights Agreement, dated as of February 8, 1994, between the Registrant
          and  Chemical  Trust  Company  of  California,  as  Rights  Agent,  is
          incorporated  by  reference  herein to  Exhibit 1 to the  Registrant's
          Registration Statement on Form 8-A dated February 14, 1994.

     5.1* Opinion of Lowenstein Sandler PC.

     23.1* Consent of Deloitte & Touche LLP.

     23.2* Consent of Arthur Andersen LLP.

     23.3* Consent of Ernst & Young LLP.

     23.4 Consent of Lowenstein Sandler PC is included in Exhibit 5.1.

     24.1* Power of Attorney. 
_________________
* Filed herewith.



                                                                     EXHIBIT 5.1
May 3, 1999

Bergen Brunswig Corporation
4000 Metropolitan Drive
Orange, California 92868

Re:      Registration Statement on Form S-8
         1999 Management Stock Incentive Plan
         1999 Non-Employee Directors' Stock Plan

Gentlemen:

          You have  requested our opinion,  as special  securities  counsel,  in
connection  with the  registration  with the Securities and Exchange  Commission
under the  Securities Act of 1933, as amended,  of 10,750,000  shares of Class A
Common Stock, par value $1.50 per share (the "Common Stock"), of Bergen Brunswig
Corporation (the "Company") issuable from time to time pursuant to the Company's
1999 Management Stock Incentive Plan and 1999 Non-Employee Directors' Stock Plan
(collectively,  the "Plans" ). The Common  Stock is to be offered  pursuant to a
registration statement on Form S-8 (the "Registration Statement").

          We have examined and relied upon originals or copies, authenticated or
certified to our satisfaction,  of the Plans, the Company's Restated Certificate
of Incorporation  and by-laws,  as amended and restated,  and all such corporate
records of the Company,  communications  or  certifications of public officials,
certificates of officers, directors and representatives of the Company, and such
other  documents as we have deemed  relevant  and  necessary as the basis of the
opinions  expressed  herein.  In making such  examination,  we have  assumed the
genuineness of all signatures,  the authenticity of all documents tendered to us
as  originals,  and  the  conformity  to  original  documents  of all  documents
submitted to us as certified or photocopied copies.

          Based upon the foregoing and relying upon statements of fact contained
in the documents  which we have examined,  we are of the opinion that the shares
of Common Stock available for issuance under the Plans,  when issued,  delivered
and paid for in accordance  with the terms and conditions of the Plans,  will be
legally issued, fully paid and nonassessable.

          We hereby  consent to the filing of this  opinion as an exhibit to the
Registration  Statement  and  the  reference  to this  firm in the  Registration
Statement.  In giving such  consent,  we do not thereby admit that we are in the
category of persons whose consent is required  under Section 7 of the Act or the
rules and regulations of the Securities and Exchange Commission.

Very truly yours,


/s/ LOWENSTEIN SANDLER PC


                                                                   EXHIBIT 23.1

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in this  Registration  Statement of
Bergen  Brunswig  Corporation  on Form S-8  pertaining  to the  Bergen  Brunswig
Corporation  1999 Management  Stock Incentive Plan and  Non-Employee  Directors'
Stock Plan of our report  dated October 30, 1998, appearing in the Annual Report
on Form 10-K of Bergen  Brunswig  Corporation  for the year ended  September 30,
1998.



/s/ DELOITTE & TOUCHE LLP

Costa Mesa, California
May 3, 1999



                                                                   EXHIBIT 23.2

CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS

As independent  public  accountants,  we hereby consent to the  incorporation by
reference  in this  registration  statement  (Form  S-8)  pertaining  the Bergen
Brunswig  Corporation  1999  Management  Stock  Incentive Plan and  Non-Employee
Directors'  Stock Plan of our reports  dated  February 26, 1999 for  PharMerica,
Inc. included in the Bergen Brunswig Corporation's Form 8-K dated April 30, 1999
and to all references to our Firm included in this registration statement.


                                                  /s/ Arthur Andersen

Baltimore, Maryland
May 3, 1999



                                                                   EXHIBIT 23.3
CONSENT OF ERNST & YOUNG LLP, INDEPENDENT AUDITORS

We consent to the incorporation by reference in the Registration Statement (Form
S-8)  pertaining  to the  Bergen  Brunswig  Corporation  1999  Management  Stock
Incentive Plan and Non-Employee  Directors' Stock Plan of our report dated April
18,  1997,  with  respect  to the 1996  consolidated  financial  statements  and
schedule of  PharMerica,  Inc.  (formerly  Pharmacy  Corporation of America) and
subsidiaries  included in the Bergen  Brunswig Corporation  Current Report (Form
8-K) dated April 30, 1999,  filed with the  Securities  and Exchange Commission.

                                             /s/ Ernst & Young LLP

Little Rock, Arkansas
May 3, 1999





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission